IPP Bureau
Bayer receives first approval for Lynkuet in UK as treatment for vasomotor symptoms associated with menopause
By IPP Bureau - July 11, 2025
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
FDA approves Bravecto Quantum from Merck Animal Health
By IPP Bureau - July 11, 2025
FDA accepts new drug application for Merck’s Doravirine/Islatravir
By IPP Bureau - July 11, 2025
The FDA set a target action date of April 28, 2026, under the Prescription Drug User Fee Act
Pfizer and Astellas' Xtandi combo extends survival in early prostate cancer setting
By IPP Bureau - July 11, 2025
Xtandi is approved in over 80 countries, including the U.S., EU, and Japan
Takara Bio Europe inks distribution agreement with Macherey-Nagel
By IPP Bureau - July 11, 2025
Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxembourg, Sweden, Switzerland, and the United Kingdom
Merck to acquire Verona Pharma for US$ 10 billion
By IPP Bureau - July 10, 2025
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases
82% of people prefer diagnostic centers over hospitals for preventive checkups in India
By IPP Bureau - July 10, 2025
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
By IPP Bureau - July 09, 2025
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
Merck to present new research data across its HIV prevention and treatment pipeline at IAS 2025
By IPP Bureau - July 09, 2025
Additional data will be presented on a once-weekly oral combination of islatravir and ulonivirine (ISL/ULO) for HIV-1 treatment
Novo Nordisk submits application to EMA for higher dose of Wegovy for obesity treatment
By IPP Bureau - July 09, 2025
The submission is based on data from the STEP UP and STEP UP T2D clinical trials
Merck KGaA bestows 2025 Future Insight Prize to Helmholtz Center’s Magdalena Gotz for breakthroughs in brain regeneration
By IPP Bureau - July 09, 2025
Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
BioMed X and Servier launch AI-powered antibody research at New XSeed Labs in Paris-Saclay
By IPP Bureau - July 09, 2025
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
IMCD opens life science laboratory hub in Shanghai
By IPP Bureau - July 09, 2025
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
Seeds of Innocence launches Asia’s first at-home IVF platform
By IPP Bureau - July 09, 2025
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
CARE Hospitals, Hitech City introduces AI-powered robotic surgery system
By IPP Bureau - July 09, 2025
The Stryker Mako Robotic System uses artificial intelligence to improve surgical accuracy with real-time guidance, personalized planning, and precise execution
